Proteomic analysis of Down syndrome cerebrospinal fluid compared to late-onset and autosomal dominant Alzheimer´s disease

Abstract Almost all individuals with Down Syndrome (DS) develop Alzheimer’s disease (AD) by mid to late life. However, the degree to which AD in DS shares pathological changes with sporadic late-onset AD (LOAD) and autosomal dominant AD (ADAD) beyond core AD biomarkers such as amyloid-β (Aβ) and tau...

Descripción completa

Detalles Bibliográficos

Autores principales:	Laia Montoliu-Gaya, Shijia Bian, Eric B. Dammer, Daniel Alcolea, Mathias Sauer, Mitchell Martá-Ariza, Nicholas J. Ashton, Olivia Belbin, Johannes Fuchs, Caroline M. Watson, Lingyan Ping, Duc M. Duong, Johanna Nilsson, Isabel Barroeta, Juan Lantero-Rodriguez, Laura Videla, Bessy Benejam, Blaine R. Roberts, Kaj Blennow, Nicholas T. Seyfried, Allan I. Levey, María Carmona-Iragui, Johan Gobom, Alberto Lleó, Thomas Wisniewski, Henrik Zetterberg, Juan Fortea, Erik C. B. Johnson
Formato:	Artigo
Lenguaje:	Inglês
Publicado:	Nature Portfolio 2025-07-01
Colección:	Nature Communications
Acceso en línea:	https://doi.org/10.1038/s41467-025-61054-z
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!